Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Clinical Outcomes and Risks in Post-Ibrutinib Transplant

April 5, 2026
Continue Reading
clinical-outcomes-and-risks-in-post-ibrutinib-transplant
Posted inBiotechnology

Whole-Body MRI Predicts Ovarian Cancer Treatment Outcomes

April 5, 2026
Continue Reading
whole-body-mri-predicts-ovarian-cancer-treatment-outcomes
Posted inBiotechnology

Distributed Fusion Framework Predicts Breast Cancer Recurrence

April 5, 2026
Continue Reading
distributed-fusion-framework-predicts-breast-cancer-recurrence
Posted inBiotechnology

Inside TCF3::HLF-Positive B-ALL: Clinical and Molecular Insights

April 4, 2026
Continue Reading
inside-tcf3::hlf-positive-b-all:-clinical-and-molecular-insights
Posted inBiotechnology

Frailty, Nutrition, Depression Impact Elderly Quality of Life

April 4, 2026
Continue Reading
frailty,-nutrition,-depression-impact-elderly-quality-of-life
Posted inBiotechnology

Multi-Stacked BiLSTM Enhances Twitter Sentiment Analysis

April 4, 2026
Continue Reading
multi-stacked-bilstm-enhances-twitter-sentiment-analysis
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

astellas-pays-sangamo-$20m-upfront-to-improve-neurological-gene-therapy-capabilities
Posted inBiotechnology

Astellas pays Sangamo $20M upfront to improve neurological gene therapy capabilities

December 19, 2024
Astellas is continuing to strengthen its neurological disease gene therapy capabilities, handing Sangamo Therapeutics $20 million upfront to help bypass…
Read More
akamis-bio-raises-$60-million-for-cancer-gene-therapy,-signs-licensing-deal-with-xuanzhu-biopharma
Posted inGenetics

Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma

December 19, 2024
Akamis Bio, a clinical-stage oncology company, has raised $60 million in Series A funding that will drive continued development of…
Read More
mechanisms-underlying-sjogren’s-disease-outlined-in-mice;-existing-drug-shows-therapeutic-promise
Posted inGenetics

Mechanisms Underlying Sjögren’s Disease Outlined in Mice; Existing Drug Shows Therapeutic Promise

December 19, 2024
Researchers at NYU College of Dentistry and NYU Grossman School of Medicine reported the findings of a study in mice…
Read More
how-fungi-make-a-promising-compound-for-treating-cancer-and-inflammation
Posted inGenetics

How Fungi Make a Promising Compound for Treating Cancer and Inflammation

December 18, 2024
The process by which fungi synthesize some of their most potent compounds has remained unclear for many years. This is…
Read More
xgen-venture-closes-$190m-fund-with-plans-to-invest-in-early-stage-biotech,-medtech-firms
Posted inBiotechnology

XGEN Venture closes $190M fund with plans to invest in early-stage biotech, medtech firms

December 18, 2024
Italian VC XGEN Venture has closed a 180 million euro ($190 million) fund for biotech and medtech companies. The life…
Read More
labcorp-launches-bird-flu-test-amid-first-severe-case-in-the-us
Posted inMedical Technology

Labcorp launches bird flu test amid first severe case in the US

December 18, 2024
Amid reports of the first severe human case of bird flu in the U.S., Labcorp has launched a molecular diagnostic…
Read More
the-state-of-cell-and-gene-therapy-2025
Posted inGenetics

The State of Cell and Gene Therapy 2025

December 18, 2024
Broadcast Date:  Wednesday, January 29, 2025Time:  8:00 am PT, 11:00 am ET, 17:00 CET The field of cell and gene…
Read More
alphabet-spinoff-sandboxaq-raises-$300m-fund-for-‘next-wave-of-ai’
Posted inBiotechnology

Alphabet spinoff SandboxAQ raises $300M fund for ‘next wave of AI’

December 18, 2024
Alphabet spinoff SandboxAQ has raised more than $300 million to go toward developing AI applications across multiple areas including drug…
Read More
lawsuit-accuses-applied-therapeutics-of-misleading-investors-before-fda-rejection
Posted inBiotechnology

Lawsuit accuses Applied Therapeutics of misleading investors before FDA rejection

December 18, 2024
After its rare disease drug was rejected by the FDA in late November, Applied Therapeutics vowed to fight on with…
Read More
editor’s-corner:-fierce-biotech’s-10-most-read-stories-of-2024
Posted inBiotechnology

Editor’s Corner: Fierce Biotech’s 10 most-read stories of 2024

December 18, 2024
For the end of this year, Fierce Biotech is taking the opportunity to reflect on trends emerging from 2024’s reporting.…
Read More

Posts pagination

Previous page 1 … 1,626 1,627 1,628 1,629 1,630 … 1,639 Next page
You May Have Missed
epia-neuro-launches-with-bci-device-to-help-stroke-patients-rework-brain-signals
Posted inMedical Technology

Epia Neuro launches with BCI device to help stroke patients rework brain signals

premier-radiology-acquires-teleradiology-specialist-globis
Posted inMedical Technology

Premier Radiology acquires teleradiology specialist GLOBIS

cancer-screening-costs-rival-diagnosis-fears-as-patients-fall-behind
Posted inMedical Technology

Cancer screening costs rival diagnosis fears as patients fall behind

whoop-raises-$575m-series-g,-abbott-comes-on-board-amid-hiring-spree
Posted inMedical Technology

Whoop raises $575M series G, Abbott comes on board amid hiring spree

Privacy Policy    Terms

Scroll to Top